The present invention relates to derivatives of
N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-dip-
henylacetamide with covalently bonded acids, and to the salts, solvates
and prodrugs thereof, to the derivatives as medicaments, to the use of
these derivatives for the preparation of a medicament, to the use of
these derivatives for the preparation of a pharmaceutical composition, to
a process for the preparation of the said pharmaceutical compositions, to
pharmaceutical compositions obtainable by this process, and to a process
for the treatment of diseases which comprises the administration of the
said pharmaceutical composition.
